Leadership Team
We are dedicated to developing medical solutions that have the potential to help people living with deep venous disease to re-enjoy life’s simple pleasures.

Robert Berman
Chief Executive Officer, Director
Read More

Marc Glickman, M.D.
Senior Vice President and Chief Medical Officer
Read More

Jennifer Bright
Chief Financial Officer
Read More

Hamed Alavi, Ph.D.
Senior Vice President and Chief Technology Officer
Read More

Sandy Prietto
Vice President, Marketing
Read More

Avi Sharma
Senior Vice President, Clinical, Regulatory and Quality
Read More
Robert Berman
Chief Executive Officer, Director
Robert Berman has served as our Chief Executive Officer and a member of our Board of Directors since April of 2018, during which time he has successfully transitioned the company from being a small private company focused on cardiac care, to a publicly traded entity focused on venous disease. Mr. Berman has over 25 years of experience in a broad variety of areas including healthcare, finance, acquisitions, marketing, compliance, turnarounds, and the development and licensing of emerging technologies. From September 2012 until July 2017, he served as the President, Chief Executive Officer, and a member of the Board of Directors of ITUS Corporation (now called Anixa Biosciences), which at the time he joined the company was a developer of flat panel display technologies, and under his leadership became a Nasdaq listed cancer therapeutics company. From 2000 to March 2007, Mr. Berman was the Chief Operating Officer and General Counsel of Acacia Research Corporation, where he successfully transitioned the company from being an incubator of internet startups into the preeminent, publicly traded company for licensing and enforcing patented technologies with a market cap exceeding $2 billion. Mr. Berman started his career at the law firm of Blank Rome. Mr. Berman has a B.S. in Entrepreneurial Management from the Wharton School of the University of Pennsylvania and holds a J.D. from the Northwestern University School of Law, where he is an adjunct faculty member.
Marc Glickman, M.D.
Senior Vice President and Chief Medical Officer
Marc H. Glickman, M.D. has served as our Senior Vice President and Chief Medical Officer since May 2016 and served as member of our board of directors from July 2016 to August 2017. In 1981, Dr. Glickman started a vascular practice in Norfolk, Virginia. He established the first Vein Center in Virginia and also created a dialysis access center. He was employed by Sentara Health Care as director of Vascular Services until he retired in 2014. Dr. Glickman received his Doctor of Medicine from Case Western Reserve, in Cleveland, Ohio and completed his residency at the University of Washington, Seattle. He is board certified in Vascular Surgery and was the past president of the Vascular Society of the Americas. He has served on the advisory boards of Possis Medical, Cohesion Technologies, Thoratec, GraftCath, Inc., TVA medical, Austin, Texas.
Jennifer Bright
Chief Financial Officer
Jennifer Bright joined enVVeno in May 2025. Ms. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP. She is a Certified Public Accountant and received a B.A. degree in Business Administration, Accounting, from the University of Washington.
Hamed Alavi, Ph.D.
Senior Vice President and Chief Technology Officer
Hamed Alavi, Ph.D. is an innovative leader with a successful track record of developing state-of-the-art medical device technologies in both startup and large corporate environments. Prior to joining enVVeno, Dr. Alavi was the head of engineering at NaviGate Cardiac Structures Inc., a startup which develops cutting edge tricuspid heart valve replacement and delivery system devices. This and his previous roles at Medtronic Cardiac and Vascular Group (CVG) and Edwards Lifesciences Center for Advanced Cardiovascular Technology allowed him to use his unparalleled vision, and technical and leadership skills to drive early-stage medical device technologies from conception to commercialization. Dr. Alavi received his doctorate in biomedical engineering from University of California, Irvine where he was trained in one of the most prominent cardiovascular engineering doctoral programs in the US. His pioneering work in hybrid tissue and implantable medical devices was broadly recognized and given accolades by a number of institutions – such as the American Heart Association. He also holds an M.S. degree in biomedical engineering and a B.S. degree in mechanical engineering.
Kevin Belteau
Vice President of Clinical Operations
Kevin Belteau joined enVVeno Medical in August 2022 following a twenty-three-year career in clinical operations at Medtronic. Upon graduation from college, Mr. Belteau began at Medtronic as a field engineer and has progressed through various clinical operations roles over the course of his tenure there. Most recently he managed his own team of clinical operations professionals and has been directly involved in more than 75 clinical studies for class III medical devices seeking PMA approval. Mr. Belteau received a Masters in Business Administration from University of South Florida and a Bachelor of Science in Biomedical Engineering from Texas A&M University.
Sandy Prietto
Vice President, Marketing
Sandy Prietto is a seasoned MedTech marketing executive. For over 17 years she has led successful product launches, fostering strategic partnerships along the way. Prior to joining enVVeno, Ms. Prietto served as Head of Worldwide Marketing at Endologix where she oversaw the successful launch of the DETOUR™ System. Her previous experience also includes key leadership roles at Edwards Lifesciences, where she oversaw new therapy launches and led U.S. therapy development initiatives within the Surgical and TAVR divisions. Ms. Prietto holds a Bachelor’s degree in Psychology from California State University, Fullerton.
